For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Warfarin sodium - Atrial fibrillation
PAD Profile : Warfarin sodium - Atrial fibrillation
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Apixaban
- Dabigatran etexilate
- Dronedarone hydrochloride
- Rivaroxaban
- Aspirin
- Edoxaban
- Acenocoumarol
- Phenindione
Other Indications
No indications returned.
Additional Documents
Committee Recommendations
The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed the updated Surrey Heartlands Oral Anticoagulant selection tool in Atrial Fibrillation.
Apixaban is now the recommended 1st-line DOAC in accordance with the updated NHSE Commissioning Recommendations.
Apixaban is available generically and is the most cost-effective DOAC.
Refer to the Oral Anticoagulation Selection Tool for full guidance.
The Surrey Heartlands ICS Area Prescribing Committee have agreed the use of an ORBIT-bleed risk scoring tool when considering or reviewing anticoagulant treatment in Atrial Fibrillation (AF).
The Surrey & North West Sussex Area Prescribing Committee have agreed the updated guidance on calculating creatinine clearance for DOACs.